We are live on
!
Find out more
Cetera Investment Advisers Portfolio holdings
AUM
$94B
1-Year Est. Return
20.14%
This Fund
S&P 500
This Quarter
Est. Return
+2.24%
1 Year Est. Return
+20.14%
3 Year Est. Return
+58.25%
5 Year Est. Return
+64.18%
10 Year Est. Return
+205.32%
AUM
$91.5B
AUM Growth
+$5.45B
(+6.3%)
Cap. Flow
+$4.11B
Cap. Flow
% of AUM
4.49%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
4,916
New
350
Increased
2,508
Reduced
1,736
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$131M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$93.3M |
| 3 |
Capital Group Dividend Value ETF
CGDV
|
+$89.4M |
| 4 |
Fidelity Total Bond ETF
FBND
|
+$83.7M |
| 5 |
Fidelity Enhanced International ETF
FENI
|
+$77.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$102M |
| 2 |
Janus Henderson Short Duration Income ETF
VNLA
|
+$47.8M |
| 3 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$38.8M |
| 4 |
iShares International Dividend Growth ETF
IGRO
|
+$28.4M |
| 5 |
FT Vest Growth-100 Buffer ETF December
QDEC
|
+$28.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.92% |
| 2 | Financials | 4.18% |
| 3 | Consumer Discretionary | 3.07% |
| 4 | Industrials | 2.77% |
| 5 | Healthcare | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4501
Oxford Square Capital
OXSQ
$152M
| $42.3K | ﹤0.01% |
24,042
+544
| +2% | +$990 |
|
4502
Milestone Pharmaceuticals
MIST
$157M
| $41.9K | ﹤0.01% |
+20,722
| New | +$44.6K |
|
4503
Xerox
XRX
$427M
| $41.3K | ﹤0.01% |
17,423
-609
| -3% | -$1.8K |
|
4504
SKYX Platforms
SKYX
$164M
| $41.2K | ﹤0.01% |
18,990
| – | – |
|
|
AISP
4505
Airship AI Holdings
AISP
$69.9M
| $41.1K | ﹤0.01% |
14,224
+1,875
| +15% | +$7.72K |
|
4506
Sabre
SABR
$835M
| $40.9K | ﹤0.01% |
30,082
+2,251
| +8% | +$3.88K |
|
|
PLG
4507
Platinum Group Metals
PLG
$203M
| $40.5K | ﹤0.01% |
17,180
+700
| +4% | +$1.69K |
|
4508
Ironwood Pharmaceuticals
IRWD
$669M
| $40.3K | ﹤0.01% |
11,949
| – | – |
|
4509
Sidus Space
SIDU
$238M
| $40.2K | ﹤0.01% |
12,814
+727
| +6% | +$839 |
|
4510
Eledon Pharmaceuticals
ELDN
$284M
| $40.1K | ﹤0.01% |
26,584
+11,207
| +73% | +$26.6K |
|
4511
Upexi
UPXI
$59.1M
| $39.7K | ﹤0.01% |
23,660
+6,540
| +38% | +$24.7K |
|
|
IAUX
4512
i-80 Gold Corp
IAUX
$1.47B
| $39.5K | ﹤0.01% |
26,800
+15,800
| +144% | +$18K |
|
4513
AbCellera Biologics
ABCL
$2.85B
| $38.4K | ﹤0.01% |
11,228
-47
| -0.4% | -$210 |
|
|
BZAI
4514
Blaize Holdings
BZAI
$147M
| $38.3K | ﹤0.01% |
+19,659
| New | +$63.6K |
|
4515
NeoVolta
NEOV
$153M
| $38K | ﹤0.01% |
12,500
| – | – |
|
4516
Lantern Pharma
LTRN
$35.9M
| $37.1K | ﹤0.01% |
+12,228
| New | +$45.5K |
|
|
ABTC
4517
American Bitcoin Corp
ABTC
$515M
| $36.2K | ﹤0.01% |
1,419
+574
| +68% | +$35.9K |
|
4518
Femasys
FEMY
$7.16M
| $35.7K | ﹤0.01% |
+3,100
| New | +$47K |
|
4519
Absci
ABSI
$1.53B
| $35.7K | ﹤0.01% |
10,217
-1,192
| -10% | -$4.34K |
|
4520
Anixa Biosciences
ANIX
$111M
| $34.7K | ﹤0.01% |
+11,127
| New | +$45.6K |
|
4521
Prairie Operating Co
PROP
$79.7M
| $34.2K | ﹤0.01% |
20,246
-2,054
| -9% | -$3.73K |
|
4522
Microvision
MVIS
$88.5M
| $33.5K | ﹤0.01% |
2,700
-74
| -3% | -$1.18K |
|
|
FLNA
4523
Filana Therapeutics
FLNA
$48.2M
| $33.4K | ﹤0.01% |
16,889
+126
| +0.8% | +$403 |
|
4524
Editas Medicine
EDIT
$432M
| $33K | ﹤0.01% |
16,088
| – | – |
|
4525
Banco Bradesco
BBDO
$34.6B
| $32.5K | ﹤0.01% |
+11,322
| New | +$33.8K |
|
Similar funds
Cetera Investment Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, Cetera Investment Advisers held 4,916 positions worth $91.5B, up 6.3% from $86B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Cetera Investment Advisers deployed $4.11B of net new capital in Q4 2025, opening 350 new positions and adding to 2,508 existing holdings. Its largest new stake was Bluerock Private Real Estate Fund: 3,212,160 shares worth $48.2M.
By sector, the portfolio is most concentrated in Technology at 9.9% of assets, down from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares MSCI USA Quality Factor ETF, an estimated $102M trimmed.
- Cetera Investment Advisers's largest Q4 2025 buy was Bluerock Private Real Estate Fund: 3,212,160 shares worth $48.2M.
- Cetera Investment Advisers added most to iShares S&P 500 Value ETF in Q4 2025, an estimated $131M increase.
- Cetera Investment Advisers's biggest Q4 2025 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $102M.
- Cetera Investment Advisers fully exited Invesco BulletShares 2025 High Yield Corporate Bond ETF in Q4 2025, selling an estimated $22.6M.
- Cetera Investment Advisers's ten largest holdings make up 17% of its $91.5B portfolio in Q4 2025.
- Cetera Investment Advisers opened 350 new positions and closed 231 in Q4 2025.
- Cetera Investment Advisers's portfolio value rose 6.3% quarter-over-quarter to $91.5B.
Based on Cetera Investment Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.